Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time ; volume:10 ; number:1 ; day:1 ; month:5 ; year:2024 ; pages:1-6 ; date:12.2024
Cardio-Oncology ; 10, Heft 1 (1.5.2024), 1-6, 12.2024
- Urheber
-
Shaaban, Adnan
Petersen, Ashley
Beckwith, Heather
Florea, Natalia
Potter, David A.
Yee, Douglas
Vogel, Rachel I.
Duprez, Daniel
Blaes, Anne H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-024-00227-z
- URN
-
urn:nbn:de:101:1-2407122131111.452984566778
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
04.04.0004, 10:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shaaban, Adnan
- Petersen, Ashley
- Beckwith, Heather
- Florea, Natalia
- Potter, David A.
- Yee, Douglas
- Vogel, Rachel I.
- Duprez, Daniel
- Blaes, Anne H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis